Santosh S. Kulkarni

973 total citations
29 papers, 822 citations indexed

About

Santosh S. Kulkarni is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Santosh S. Kulkarni has authored 29 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 6 papers in Organic Chemistry. Recurrent topics in Santosh S. Kulkarni's work include Receptor Mechanisms and Signaling (13 papers), Neuroscience and Neuropharmacology Research (10 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Santosh S. Kulkarni is often cited by papers focused on Receptor Mechanisms and Signaling (13 papers), Neuroscience and Neuropharmacology Research (10 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Santosh S. Kulkarni collaborates with scholars based in United States, India and France. Santosh S. Kulkarni's co-authors include Amy Hauck Newman, Vithal M. Kulkarni, Jay P. McLaughlin, Jonathan L. Katz, Theresa Kopajtic, Nicolette C. Ross, Jane V. Aldrich, Debomoy K. Lahiri, Damon A. Parrish and Weiming Luo and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Santosh S. Kulkarni

28 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Santosh S. Kulkarni United States	19	453	292	292	170	145	29	822
Daniele Pala Italy	19	461 1.0×	271 0.9×	216 0.7×	111 0.7×	78 0.5×	37	862
Siem J. Veenstra Switzerland	16	342 0.8×	143 0.5×	404 1.4×	130 0.8×	99 0.7×	30	748
Munikumar Reddy Doddareddy South Korea	21	551 1.2×	134 0.5×	292 1.0×	198 1.2×	99 0.7×	37	928
Samuel T. Slocum United States	10	572 1.3×	304 1.0×	133 0.5×	133 0.8×	104 0.7×	14	867
Marc M. Kurtz United States	17	750 1.7×	303 1.0×	389 1.3×	95 0.6×	152 1.0×	36	1.3k
Bellinda Benhamú Spain	25	1.0k 2.3×	449 1.5×	597 2.0×	178 1.0×	157 1.1×	60	1.6k
Thea Mulder‐Krieger Netherlands	20	796 1.8×	246 0.8×	457 1.6×	187 1.1×	57 0.4×	26	1.3k
Yong Seo Cho South Korea	22	578 1.3×	126 0.4×	809 2.8×	191 1.1×	167 1.2×	92	1.3k
Savina Ferorelli Italy	20	628 1.4×	143 0.5×	353 1.2×	61 0.4×	148 1.0×	56	992
Livio Brasili Italy	23	863 1.9×	437 1.5×	455 1.6×	119 0.7×	107 0.7×	99	1.2k

Countries citing papers authored by Santosh S. Kulkarni

Since Specialization

Citations

This map shows the geographic impact of Santosh S. Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Santosh S. Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Santosh S. Kulkarni more than expected).

Fields of papers citing papers by Santosh S. Kulkarni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Santosh S. Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Santosh S. Kulkarni. The network helps show where Santosh S. Kulkarni may publish in the future.

Co-authorship network of co-authors of Santosh S. Kulkarni

This figure shows the co-authorship network connecting the top 25 collaborators of Santosh S. Kulkarni. A scholar is included among the top collaborators of Santosh S. Kulkarni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Santosh S. Kulkarni. Santosh S. Kulkarni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lagu, Bharat, Santosh S. Kulkarni, R. J. Paul, et al.. (2022). Orally Bioavailable Enzymatic Inhibitor of CD38, MK-0159, Protects against Ischemia/Reperfusion Injury in the Murine Heart. Journal of Medicinal Chemistry. 65(13). 9418–9446. 12 indexed citations

Greig, Nigel H., Arnold Brossi, Santosh S. Kulkarni, et al.. (2020). Inhibition of Human Acetyl- and Butyrylcholinesterase by Novel Carbamates of (−)- and (+)-Tetrahydrofurobenzofuran and Methanobenzodioxepine. Figshare.

Kulkarni, Santosh S., et al.. (2018). Current Trends in Internet of Things A Survey. International Journal of Computer Sciences and Engineering. 6(6). 1223–1226. 3 indexed citations

Kulkarni, Santosh S., et al.. (2017). Communication Models in Internet of Things: A Survey. International Journal For Science Technology And Engineering. 3(11). 87–91. 6 indexed citations

Sauer, Wolfgang, et al.. (2014). Enantioselective Synthesis and Physicochemical Properties of Libraries of 3‐Amino‐ and 3‐Amidofluoropiperidines. Chemistry - A European Journal. 20(13). 3813–3824. 27 indexed citations

Aldrich, Jane V., Santosh S. Kulkarni, Nicolette C. Ross, et al.. (2011). Unexpected Opioid Activity Profiles of Analogues of the Novel Peptide Kappa Opioid Receptor Ligand CJ‐15,208. ChemMedChem. 6(9). 1739–1745. 32 indexed citations

Ross, Nicolette C., Santosh S. Kulkarni, Jay P. McLaughlin, & Jane V. Aldrich. (2010). Synthesis of CJ-15,208, a novel κ-opioid receptor antagonist. Tetrahedron Letters. 51(38). 5020–5023. 26 indexed citations

Kulkarni, Santosh S., Nicolette C. Ross, Jay P. McLaughlin, & Jane V. Aldrich. (2009). Synthesis of Cyclic Tetrapeptide CJ 15,208: A Novel Kappa Opioid Receptor Antagonist. Advances in experimental medicine and biology. 611. 269–270. 11 indexed citations

Kulkarni, Santosh S., Mu‐Fa Zou, Jianjing Cao, et al.. (2009). Structure−Activity Relationships Comparing N-(6-Methylpyridin-yl)-Substituted Aryl Amides to 2-Methyl-6-(substituted-arylethynyl)pyridines or 2-Methyl-4-(substituted-arylethynyl)thiazoles as Novel Metabotropic Glutamate Receptor Subtype 5 Antagonists. Journal of Medicinal Chemistry. 52(11). 3563–3575. 37 indexed citations

10.

Kulkarni, Santosh S. & Amy Hauck Newman. (2007). Discovery of heterobicyclic templates for novel metabotropic glutamate receptor subtype 5 antagonists. Bioorganic & Medicinal Chemistry Letters. 17(11). 2987–2991. 50 indexed citations

11.

Kulkarni, Santosh S. & Amy Hauck Newman. (2007). Design and synthesis of novel heterobiaryl amides as metabotropic glutamate receptor subtype 5 antagonists. Bioorganic & Medicinal Chemistry Letters. 17(7). 2074–2079. 23 indexed citations

12.

Vaughan, Roxanne A., Dhananjay Sakrikar, James D. Foster, et al.. (2007). Localization of Cocaine Analog [125I]RTI 82 Irreversible Binding to Transmembrane Domain 6 of the Dopamine Transporter. Journal of Biological Chemistry. 282(12). 8915–8925. 20 indexed citations

13.

Luo, Weiming, Qian‐sheng Yu, Santosh S. Kulkarni, et al.. (2006). Inhibition of Human Acetyl- and Butyrylcholinesterase by Novel Carbamates of (−)- and (+)-Tetrahydrofurobenzofuran and Methanobenzodioxepine. Journal of Medicinal Chemistry. 49(7). 2174–2185. 68 indexed citations

14.

Kulkarni, Santosh S., et al.. (2006). Design and synthesis of noncompetitive metabotropic glutamate receptor subtype 5 antagonists. Bioorganic & Medicinal Chemistry Letters. 16(13). 3371–3375. 13 indexed citations

15.

Kulkarni, Santosh S., Theresa Kopajtic, Jonathan L. Katz, & Amy Hauck Newman. (2006). Comparative structure–activity relationships of benztropine analogues at the dopamine transporter and histamine H1 receptors. Bioorganic & Medicinal Chemistry. 14(11). 3625–3634. 11 indexed citations

16.

Ukairo, Okechukwu, Corry D. Bondi, Amy Hauck Newman, et al.. (2005). Recognition of Benztropine by the Dopamine Transporter (DAT) Differs from That of the Classical Dopamine Uptake Inhibitors Cocaine, Methylphenidate, and Mazindol as a Function of a DAT Transmembrane 1 Aspartic Acid Residue. Journal of Pharmacology and Experimental Therapeutics. 314(2). 575–583. 39 indexed citations

17.

Brown, LaVerne L., Santosh S. Kulkarni, Olga Pavlova, et al.. (2002). Synthesis and Evaluation of a Novel Series of 2-Chloro-5-((1-methyl-2-(S)-pyrrolidinyl)methoxy)-3-(2-(4-pyridinyl)vinyl)pyridine Analogues as Potential Positron Emission Tomography Imaging Agents for Nicotinic Acetylcholine Receptors. Journal of Medicinal Chemistry. 45(13). 2841–2849. 23 indexed citations

18.

Newman, Amy Hauck & Santosh S. Kulkarni. (2002). Probes for the dopamine transporter: New leads toward a cocaine‐abuse therapeutic—A focus on analogues of benztropine and rimcazole. Medicinal Research Reviews. 22(5). 429–464. 90 indexed citations

19.

Kulkarni, Santosh S. & Vithal M. Kulkarni. (1999). Three-Dimensional Quantitative Structure−Activity Relationship of Interleukin 1-β Converting Enzyme Inhibitors: A Comparative Molecular Field Analysis Study. Journal of Medicinal Chemistry. 42(3). 373–380. 58 indexed citations

20.

Kulkarni, Santosh S., Lalji K. Gediya, & Vithal M. Kulkarni. (1999). Three-dimensional quantitative structure activity relationships (3-D-QSAR) of antihyperglycemic agents. Bioorganic & Medicinal Chemistry. 7(7). 1475–1485. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact